KBC Group NV Reduces Position in Healthpeak Properties, Inc. (NYSE:DOC)

KBC Group NV decreased its position in Healthpeak Properties, Inc. (NYSE:DOC) by 75.5% in the fourth quarter, HoldingsChannel.com reports. The fund owned 187,069 shares of the real estate investment trust’s stock after selling 575,402 shares during the period. KBC Group NV’s holdings in Healthpeak Properties were worth $3,792,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Healthpeak Properties in the second quarter worth about $66,000. Healthcare of Ontario Pension Plan Trust Fund purchased a new position in Healthpeak Properties during the 2nd quarter worth approximately $9,024,000. Centaurus Financial Inc. acquired a new stake in Healthpeak Properties during the 2nd quarter valued at approximately $227,000. Massmutual Trust Co. FSB ADV purchased a new stake in shares of Healthpeak Properties in the 3rd quarter valued at $108,000. Finally, AMF Tjanstepension AB acquired a new stake in shares of Healthpeak Properties in the third quarter worth $15,548,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Trading Up 0.7 %

Shares of Healthpeak Properties stock opened at $20.66 on Friday. The company has a current ratio of 1.31, a quick ratio of 1.31 and a debt-to-equity ratio of 0.93. Healthpeak Properties, Inc. has a twelve month low of $16.01 and a twelve month high of $23.26. The firm has a market capitalization of $14.45 billion, a PE ratio of 43.96, a P/E/G ratio of 2.18 and a beta of 1.14. The firm’s 50-day moving average price is $20.75 and its 200 day moving average price is $21.55.

Wall Street Analyst Weigh In

Several equities research analysts have commented on the stock. Wells Fargo & Company lowered their price target on shares of Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 10th. Robert W. Baird raised their target price on Healthpeak Properties from $24.00 to $25.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. StockNews.com downgraded Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Wednesday, October 30th. Deutsche Bank Aktiengesellschaft raised shares of Healthpeak Properties from a “hold” rating to a “buy” rating and raised their price objective for the stock from $20.00 to $28.00 in a research note on Monday, October 21st. Finally, Royal Bank of Canada boosted their target price on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $24.15.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.